HEMATOLOGY ANALYZER MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Key Developments

• On February 06, 2024, Sysmex Corporation, a global leader in in vitro diagnostics, announced that it had formed a strategic alliance with CellaVision AB, a world-leading provider of digital hematology microscopy solutions, to advance hematology solutions by expanding its portfolio, which includes next-generation cell morphology analyzers
• On January 04, 2024, HORIBA Medical, a manufacturer of in-vitro diagnostic products, announced the launch of the new HELO 2.0 high-throughput automated hematology platform, which is CE-IVDR approved and awaiting U.S. Food and Drug Administration (FDA) certification. Following the success of HORIBA Medical's prior HELO, this next generation high-end hematology line was developed in collaboration with customers to further improve and meet all of the needs of high throughput fully automated hematology.
• In August 2023, Abbott, a medical technology company, announced that its advanced Alinity h-series hematology system had been cleared by the U.S. FDA, allowing laboratories across the country to perform complete blood counts (CBC) as part of Abbott's Alinity diagnostic product family. The Alinity h-series comprises the Alinity hq, an automated hematology analyzer, and the Alinity hs, an integrated slide maker and stainer.
• In July 2022, HORIBA Medical announced the launch of new Yumizen H500 and H550 hematology devices, which are compact benchtop hematology analyzers with improved performance, additional features, and added benefits. The new Yumizen H500 and H550 have been intended to provide a speedy and complete hematological report with a throughput of 60 tests/hour, 40 tube autonomy with continuous loading, urgent manual mode, and the ability to run samples through many analytical modes and sampling.